21-46324213-G-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_006031.6(PCNT):​c.-16G>T variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0555 in 1,606,990 control chromosomes in the GnomAD database, including 2,873 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.043 ( 211 hom., cov: 35)
Exomes 𝑓: 0.057 ( 2662 hom. )

Consequence

PCNT
NM_006031.6 5_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.135

Publications

8 publications found
Variant links:
Genes affected
PCNT (HGNC:16068): (pericentrin) The protein encoded by this gene binds to calmodulin and is expressed in the centrosome. It is an integral component of the pericentriolar material (PCM). The protein contains a series of coiled-coil domains and a highly conserved PCM targeting motif called the PACT domain near its C-terminus. The protein interacts with the microtubule nucleation component gamma-tubulin and is likely important to normal functioning of the centrosomes, cytoskeleton, and cell-cycle progression. Mutations in this gene cause Seckel syndrome-4 and microcephalic osteodysplastic primordial dwarfism type II. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2015]
PCNT Gene-Disease associations (from GenCC):
  • microcephalic osteodysplastic primordial dwarfism type II
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • Moyamoya disease
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.71).
BP6
Variant 21-46324213-G-T is Benign according to our data. Variant chr21-46324213-G-T is described in ClinVar as [Benign]. Clinvar id is 138617.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0645 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PCNTNM_006031.6 linkc.-16G>T 5_prime_UTR_variant Exon 1 of 47 ENST00000359568.10 NP_006022.3 O95613-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PCNTENST00000359568.10 linkc.-16G>T 5_prime_UTR_variant Exon 1 of 47 1 NM_006031.6 ENSP00000352572.5 O95613-1

Frequencies

GnomAD3 genomes
AF:
0.0432
AC:
6577
AN:
152176
Hom.:
212
Cov.:
35
show subpopulations
Gnomad AFR
AF:
0.0101
Gnomad AMI
AF:
0.0274
Gnomad AMR
AF:
0.0263
Gnomad ASJ
AF:
0.0562
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00890
Gnomad FIN
AF:
0.0858
Gnomad MID
AF:
0.00955
Gnomad NFE
AF:
0.0661
Gnomad OTH
AF:
0.0402
GnomAD2 exomes
AF:
0.0440
AC:
10480
AN:
238208
AF XY:
0.0439
show subpopulations
Gnomad AFR exome
AF:
0.00810
Gnomad AMR exome
AF:
0.0182
Gnomad ASJ exome
AF:
0.0563
Gnomad EAS exome
AF:
0.0000559
Gnomad FIN exome
AF:
0.0869
Gnomad NFE exome
AF:
0.0636
Gnomad OTH exome
AF:
0.0471
GnomAD4 exome
AF:
0.0568
AC:
82568
AN:
1454696
Hom.:
2662
Cov.:
31
AF XY:
0.0557
AC XY:
40258
AN XY:
723282
show subpopulations
African (AFR)
AF:
0.00824
AC:
275
AN:
33386
American (AMR)
AF:
0.0203
AC:
892
AN:
44012
Ashkenazi Jewish (ASJ)
AF:
0.0552
AC:
1430
AN:
25918
East Asian (EAS)
AF:
0.0000759
AC:
3
AN:
39534
South Asian (SAS)
AF:
0.0135
AC:
1149
AN:
85304
European-Finnish (FIN)
AF:
0.0853
AC:
4497
AN:
52718
Middle Eastern (MID)
AF:
0.0249
AC:
143
AN:
5746
European-Non Finnish (NFE)
AF:
0.0642
AC:
71174
AN:
1108022
Other (OTH)
AF:
0.0500
AC:
3005
AN:
60056
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.456
Heterozygous variant carriers
0
3777
7555
11332
15110
18887
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2562
5124
7686
10248
12810
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0432
AC:
6575
AN:
152294
Hom.:
211
Cov.:
35
AF XY:
0.0423
AC XY:
3152
AN XY:
74466
show subpopulations
African (AFR)
AF:
0.0101
AC:
419
AN:
41576
American (AMR)
AF:
0.0262
AC:
401
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.0562
AC:
195
AN:
3470
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5176
South Asian (SAS)
AF:
0.00911
AC:
44
AN:
4828
European-Finnish (FIN)
AF:
0.0858
AC:
910
AN:
10612
Middle Eastern (MID)
AF:
0.0103
AC:
3
AN:
292
European-Non Finnish (NFE)
AF:
0.0661
AC:
4493
AN:
68008
Other (OTH)
AF:
0.0397
AC:
84
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
325
649
974
1298
1623
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
74
148
222
296
370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0356
Hom.:
47
Bravo
AF:
0.0375
Asia WGS
AF:
0.00924
AC:
32
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Mar 31, 2014
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Microcephalic osteodysplastic primordial dwarfism type II Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.71
CADD
Benign
7.2
DANN
Benign
0.60
PhyloP100
-0.14
PromoterAI
0.038
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.2
Mutation Taster
=296/4
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs138595914; hg19: chr21-47744127; COSMIC: COSV52449400; COSMIC: COSV52449400; API